Chapter 5

Valuation and Cash

At $3.43 an ADS, Yatsen's roughly $322 million market value sits against $145 million of net cash and a further $94 million of long-term investments — about three-quarters of the price is already on the balance sheet, leaving the operating business marked at roughly $84–177 million, or 0.14–0.29x sales. That is a fraction of what a profitable domestic peer commands. The offsets are that the cash is still shrinking, part of it is trapped in China, and $120 million of insider convertible claims now rank ahead of it.

The balance sheet inside the price

Yatsen's 1,877,236,043 ordinary shares are held as ADSs of 20 shares each, so the ~93.9 million ADS outstanding at $3.43 (28 July 2026) carry a market value near $322 million [1]. Against that price, the company held $109.4 million of cash and $35.2 million of short-term investments — $145 million of net cash, with no bank borrowings — plus $93.5 million of non-current investments, at 31 December 2025 [2].

Source: derived from the FY2025 Consolidated Balance Sheets and market data [3]; price of $3.43 as of 28 July 2026.

Strip out the cash and the operating business is valued at an enterprise value of about $177 million, or 0.29x the $614.6 million of FY2025 revenue [4]. Strip out the long-term investment portfolio as well and the residual falls to roughly $84 million — about 0.14x sales — for a business that turned over ¥4,298 million at a 78% gross margin. On that arithmetic the market assigns almost no value to the brands themselves; the price is close to the sum of the cash and the securities the company owns. This is the empirical form of the report's central question — whether the operating business is worth more than the cash on its books — and today the market's answer is: barely.

The peer gap is a margin gap

Yatsen looks cheap only in relation to something. The nearest listed comparison is Proya, the largest domestic Chinese beauty group and the peer Yatsen's own competitive positioning most resembles — digital-first, mass-to-premium skincare and colour. Proya trades at about 2.3x sales and 16x earnings; Yatsen trades at roughly a fifth of that on sales.

Sources: Yatsen FY2025 20-F [5]; Proya FY2025 results as reported (data feed); multiples on market data at 28 July 2026.

The discount is not a mystery, and it is not obviously a mispricing. The two companies sell into the same market at similar gross margins, but Proya earns a 17.6% operating margin while Yatsen loses 4.3% at the operating line. The entire gap is the marketing bill — the same conclusion reached in Marketing Economics, where selling-and-marketing spend has held near two-thirds of revenue through the crash, the skincare pivot and the store closures. A buyer paying 0.29x sales for Yatsen versus 1.9x for Proya is being compensated for exactly one thing: the risk that Yatsen never closes that margin gap. Whether the discount is opportunity or trap turns on the S&M ratio, not on the multiple.

One caution on the peer anchor: Proya is a useful yardstick for what a profitable version of this business earns, but it is not a growth comparison. Proya's own revenue was flat-to-down in 2025 (¥10.60 billion versus ¥10.78 billion the year before), so the 16x multiple prices a mature, high-margin compounder, not a re-accelerating one. Yatsen is growing faster (+26.7% in 2025) but from a loss.

Backing out a normalized margin

The cleaner way to read the price is to ask what operating profit would justify today's enterprise value. At an $177 million EV and a mid-teens EV/EBIT multiple typical of a low-growth consumer brand, the implied normalized operating profit is only about ¥85–125 million — roughly a 2–3% operating margin on current revenue. That is close to the thin non-GAAP breakeven Yatsen reached in 2025, and an order of magnitude below Proya's 17.6%.

Source: derived from FY2025 enterprise value and revenue [6]; consensus and Proya figures as reported (single-analyst estimate; data feed).

A single sell-side estimate points the same way, and its thinness is worth stating plainly: one analyst models FY2026 revenue of ¥5,238 million (+21.9%) and earnings of ¥1.56 per ADS — about ¥146 million of net income, or a 2.8% net margin — rising to ¥3.01 per ADS in FY2027, with a $4.01 price target roughly 17% above the current quote. Even that lone constructive view has Yatsen reaching only low-single-digit margins, not peer-like ones. The valuation, in other words, does not require heroics: it needs the business to hold the slim profitability it has just touched. The upside case is that if margins travel even part of the way to Proya's, the earnings — and the equity — are worth a multiple of today; the downside case is that the market has seen this before and is paying accordingly.

What sits ahead of the cash

The net-cash cushion that makes the downside look protected is real but encumbered, and three facts qualify it.

First, the cash is still leaving. Operations consumed ¥94.7 million in FY2025 and free cash flow was negative ¥138 million; the burn has narrowed but not stopped, and it continued into 2026 [7]. At that rate the ¥1.0 billion of net cash funds many years of losses, so insolvency is not the near-term risk — value erosion is, as noted in Path to Breakeven.

Second, $120 million of insider convertible notes now rank ahead of the common. The notes carry a 1.5% coupon, convert at $4.63 per ADS, and — the load-bearing term — give holders the right to require repayment for cash on the third anniversary at a 4% internal rate of return [8]. The proceeds add cash, so they do not destroy the cushion; but they subordinate it. In a wind-down the equity now sits behind roughly $120 million of senior insider claims — an amount close to the entire pre-deal net cash — and the cash put means part of that balance is pre-committed to leaving the company by year three. The full terms and the shareholder objection they provoked are in Control and Capital.

Source: FY2025 Consolidated Balance Sheets [9] and Note 23 subsequent-events disclosure [10].

Third, part of the cash is not freely accessible. As of 31 December 2025, ¥721.5 million of the group's net assets — held in its PRC subsidiaries and consolidated VIEs — were restricted from being paid out as dividends, loans or advances under Chinese law [11]. For a buyer treating the balance sheet as a floor, that trapped portion — roughly $103 million — is a genuine discount to the headline cash, and the broader China-listing overhang behind it is not yet examined in this report.

What would change the read

The valuation is two-sided and the deciding variables are observable. The case for the discount as opportunity strengthens if the selling-and-marketing ratio finally steps down while revenue holds — the single input that converts 0.29x sales from a value trap into a cheap call on margin normalization. It weakens if S&M stays near two-thirds of revenue, because then the operating business earns nothing and the cash simply drains through it, one quarter at a time. The convertible adds a second dial: the terms on which the second tranche closes, and whether repayment is taken in cash at year three, determine how much of the balance-sheet cushion actually reaches equity holders. The multiple is not the argument; the margin and the claims ahead of the cash are.